Anemia, a condition marked by a decrease in the number of red blood cells or a reduced hemoglobin concentration, is a global health concern with diverse etiologies. Understanding the diagnostic approach to anemia is crucial for healthcare professionals to ensure accurate diagnosis and effective patient management.
Anemia can be broadly classified into three categories based on the mechanism of its origin: blood loss, decreased red cell production, or increased red cell destruction. A thorough patient history and physical examination are essential in identifying the probable cause of anemia.
Initial laboratory testing includes a complete blood count (CBC) and reticulocyte count. The mean corpuscular volume (MCV) provides valuable insights into the potential cause of anemia. For instance, a low MCV suggests microcytic anemia, often caused by iron deficiency or thalassemia. A high MCV indicates macrocytic anemia, commonly due to vitamin B12 or folate deficiency, while a normal MCV is seen in normocytic anemia.
Further diagnostic procedures depend on the suspected etiology. Iron studies, serum B12 and folate levels, hemoglobin electrophoresis, or bone marrow examination may be warranted. In cases of suspected gastrointestinal blood loss, endoscopic examinations may be necessary.
Treatment is based on the underlying cause of anemia. Iron supplementation is used for iron deficiency anemia, while vitamin B12 and folate are supplemented in cases of their respective deficiencies. In severe cases or those unresponsive to medical management, blood transfusions or bone marrow transplant may be considered.
Anemia is a multifaceted disorder with a wide range of causes. A systematic approach, beginning with a thorough history and physical examination, followed by targeted laboratory investigations, is essential in unraveling the complexity of anemia and guiding appropriate treatment.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation